Marshall Wace North America L.P. decreased its stake in Universal Health Services, Inc. (NYSE:UHS) by 25.9% in the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 415,588 shares of the health services provider’s stock after selling 145,395 shares during the quarter. Marshall Wace North America L.P. owned approximately 0.45% of Universal Health Services worth $53,129,000 as of its most recent SEC filing.
A number of other institutional investors and hedge funds also recently modified their holdings of UHS. JPMorgan Chase & Co. increased its position in Universal Health Services by 57.5% in the third quarter. JPMorgan Chase & Co. now owns 3,279,863 shares of the health services provider’s stock worth $419,298,000 after buying an additional 1,196,760 shares in the last quarter. FMR LLC boosted its stake in shares of Universal Health Services by 16.9% in the second quarter. FMR LLC now owns 4,123,674 shares of the health services provider’s stock worth $459,542,000 after acquiring an additional 596,965 shares during the period. Hexavest Inc. bought a new position in shares of Universal Health Services in the third quarter worth about $58,945,000. Acadian Asset Management LLC boosted its stake in shares of Universal Health Services by 345.5% in the third quarter. Acadian Asset Management LLC now owns 558,838 shares of the health services provider’s stock worth $71,442,000 after acquiring an additional 433,401 shares during the period. Finally, Clearbridge Investments LLC boosted its stake in shares of Universal Health Services by 313.7% in the third quarter. Clearbridge Investments LLC now owns 534,952 shares of the health services provider’s stock worth $68,388,000 after acquiring an additional 405,647 shares during the period. Institutional investors and hedge funds own 89.50% of the company’s stock.
Universal Health Services stock traded down $3.69 during midday trading on Friday, reaching $127.95. 13,355 shares of the stock traded hands, compared to its average volume of 699,144. Universal Health Services, Inc. has a 12 month low of $107.00 and a 12 month high of $139.63. The firm has a market cap of $12.45 billion, a PE ratio of 17.02, a PEG ratio of 1.35 and a beta of 0.83. The company has a current ratio of 1.09, a quick ratio of 1.01 and a debt-to-equity ratio of 0.68.
Universal Health Services (NYSE:UHS) last announced its quarterly earnings results on Thursday, October 25th. The health services provider reported $2.23 EPS for the quarter, beating analysts’ consensus estimates of $2.01 by $0.22. Universal Health Services had a return on equity of 16.33% and a net margin of 7.89%. The company had revenue of $2.65 billion during the quarter, compared to analyst estimates of $2.68 billion. As a group, equities research analysts forecast that Universal Health Services, Inc. will post 9.47 earnings per share for the current fiscal year.
The company also recently declared a quarterly dividend, which will be paid on Monday, December 17th. Investors of record on Monday, December 3rd will be paid a dividend of $0.10 per share. This represents a $0.40 dividend on an annualized basis and a yield of 0.31%. The ex-dividend date of this dividend is Friday, November 30th. Universal Health Services’s payout ratio is presently 5.31%.
UHS has been the subject of a number of recent analyst reports. Barclays initiated coverage on Universal Health Services in a research note on Tuesday, August 14th. They issued an “equal weight” rating and a $135.00 price objective for the company. Zacks Investment Research lowered Universal Health Services from a “buy” rating to a “hold” rating in a research note on Thursday, August 9th. UBS Group initiated coverage on Universal Health Services in a research note on Thursday, November 15th. They issued a “buy” rating and a $156.00 price objective for the company. Leerink Swann dropped their price objective on Universal Health Services from $140.00 to $135.00 and set an “outperform” rating for the company in a research note on Monday, October 29th. Finally, Citigroup dropped their price objective on Universal Health Services from $145.00 to $140.00 and set a “buy” rating for the company in a research note on Monday, October 29th. Eight analysts have rated the stock with a hold rating and ten have given a buy rating to the stock. Universal Health Services presently has an average rating of “Buy” and a consensus price target of $137.47.
COPYRIGHT VIOLATION WARNING: This piece of content was published by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are viewing this piece of content on another domain, it was stolen and republished in violation of U.S. & international trademark and copyright legislation. The original version of this piece of content can be accessed at https://www.dispatchtribunal.com/2018/12/07/marshall-wace-north-america-l-p-has-53-13-million-holdings-in-universal-health-services-inc-uhs.html.
Universal Health Services Profile
Universal Health Services, Inc, through its subsidiaries, owns and operates acute care hospitals, outpatient facilities, and behavioral health care facilities. The company operates through Acute Care Hospital Services, Behavioral Health Care Services, and Other segments. Its hospital offer general and specialty surgery, internal medicine, obstetrics, emergency room care, radiology, oncology, diagnostic care, coronary care, pediatric services, pharmacy services, and/or behavioral health services.
Read More: Using the New Google Finance Tool
Receive News & Ratings for Universal Health Services Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Universal Health Services and related companies with MarketBeat.com's FREE daily email newsletter.